Abstract
Iron overload cardiomyopathy (IOC) is a secondary form of cardiomyopathy occurring in the setting of iron accumulation in the myocardium, mainly because of genetically determined disorders of iron metabolism (primary hemochromatosis) or multiple transfusions (secondary hemochromatosis). Two phenotypes of IOC have been identified: the dilated phenotype and the restrictive phenotype, with the former being more frequent. Cardiac magnetic resonance (CMR) has radically changed the management of patients with hemochromatosis. The T2* technique is currently the mainstay for the noninvasive quantification of myocardial iron overload (MIO) and for the design of tailor-made chelation therapies and the evaluation of their efficacy. The widespread use in clinical practice of the T2* technique contributed to open the prognosis of patients with hemochromatosis. Moreover, T1 mapping was demonstrated able to identify even small amounts of iron accumulated in the heart. Therefore, the use of both T1 and T2* mapping has been proposed as a valid means to improve the detection of mild or early MIO.
Furthermore, in hemochromatosis a multiparametric CMR approach combining the MIO quantification with tissue characterization for fibrosis and edema and with morphological and functional parameters is strongly recommended. In hemochromatosis, replacement myocardial fibrosis detected by the late gadolinium enhancement technique has emerged as a strong CMR predictor for cardiac complications and an increased extracellular volume (ECV) fraction has been demonstrated, suggesting the presence of diffuse myocardial fibrosis. In addition, the iron-induced oxidative stress and the increased risk of infections in transfused patients can trigger myocardial inflammation that can be detected by T2 mapping. The assessment of biventricular volumes and function by cine images, for which CMR is the gold standard, is crucial for the detection of heart damage, especially on the basis of the consistent number of patients showing heart dysfunction without evidence of MIO. The routinely acquired cine images can also be used for detecting the morphological criteria for non-compaction and for quantifying the myocardial deformation by ventricular strain feature tracking (FT) CMR.
In the near future, both FT-CMR and the evaluation for ECV can help in identifying treatment strategies able to bridge the gap between the onset of subclinical alterations and overt heart failure.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Kremastinos DT, Farmakis D. Iron overload cardiomyopathy in clinical practice. Circulation. 2011;124:2253–63.
Habib G, Bucciarelli-Ducci C, Caforio ALP, Cardim N, Charron P, Cosyns B, Dehaene A, Derumeaux G, Donal E, Dweck MR, Edvardsen T, Erba PA, Ernande L, Gaemperli O, Galderisi M, Grapsa J, Jacquier A, Klingel K, Lancellotti P, Neglia D, Pepe A, Perrone-Filardi P, Petersen SE, Plein S, Popescu BA, Reant P, Sade LE, Salaun E, Slart R, Tribouilloy C, Zamorano J. Multimodality imaging in restrictive cardiomyopathies: an EACVI expert consensus document in collaboration with the "working group on myocardial and pericardial diseases" of the European Society of Cardiology Endorsed by the Indian academy of echocardiography. Eur Heart J Cardiovasc Imaging. 2017;18:1090–121.
Pennell DJ, Udelson JE, Arai AE, Bozkurt B, Cohen AR, Galanello R, Hoffman TM, Kiernan MS, Lerakis S, Piga A, Porter JB, Walker JM, Wood J. Cardiovascular function and treatment in beta-thalassemia major: a consensus statement from the American Heart Association. Circulation. 2013;128:281–308.
Anderson LJ, Holden S, Davis B, Prescott E, Charrier CC, Bunce NH, Firmin DN, Wonke B, Porter J, Walker JM, Pennell DJ. Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J. 2001;22:2171–9.
Meloni A, Restaino G, Borsellino Z, Caruso V, Spasiano A, Zuccarelli A, Valeri G, Toia P, Salvatori C, Positano V, Midiri M, Pepe A. Different patterns of myocardial iron distribution by whole-heart T2* magnetic resonance as risk markers for heart complications in thalassemia major. Int J Cardiol. 2014;177:1012–9.
Pepe A, Meloni A, Rossi G, Midiri M, Missere M, Valeri G, Sorrentino F, D'Ascola DG, Spasiano A, Filosa A, Cuccia L, Dello Iacono N, Forni G, Caruso V, Maggio A, Pitrolo L, Peluso A, De Marchi D, Positano V, Wood JC. Prediction of cardiac complications for thalassemia major in the widespread cardiac magnetic resonance era: a prospective multicentre study by a multi-parametric approach. Eur Heart J Cardiovasc Imaging. 2018;19:299–309.
Meloni A, Positano V, Keilberg P, De Marchi D, Pepe P, Zuccarelli A, Campisi S, Romeo MA, Casini T, Bitti PP, Gerardi C, Lai ME, Piraino B, Giuffrida G, Secchi G, Midiri M, Lombardi M, Pepe A. Feasibility, reproducibility, and reliability for the T*(2) iron evaluation at 3 T in comparison with 1.5 T. Magn Reson Med. 2012;68:543–51.
Ramazzotti A, Pepe A, Positano V, Rossi G, De Marchi D, Brizi MG, Luciani A, Midiri M, Sallustio G, Valeri G, Caruso V, Centra M, Cianciulli P, De Sanctis V, Maggio A, Lombardi M. Multicenter validation of the magnetic resonance t2* technique for segmental and global quantification of myocardial iron. J Magn Reson Imaging. 2009;30:62–8.
Meloni A, Maggio A, Positano V, Leto F, Angelini A, Putti MC, Maresi E, Pucci A, Basso C, Perazzolo Marra M, Pistoia L, De Marchi D, Pepe A. CMR for myocardial iron overload quantification: calibration curve from the MIOT network. Eur Radiol. 2020;29:2246–52.
Pepe A, Pistoia L, Gamberini MR, Cuccia L, Lisi R, Cecinati V, Maggio A, Sorrentino F, Filosa A, Rosso R, Messina G, Missere M, Righi R, Renne S, Vallone A, Dalmiani S, Positano V, Midiri M, Meloni A. National networking in rare diseases and reduction of cardiac burden in thalassemia major. Eur Heart J. 2022;7:2482–92. https://doi.org/10.1093/eurheartj/ehab851.
Pepe A, Pistoia L, Gamberini MR, Cuccia L, Peluso A, Messina G, Spasiano A, Allo M, Bisconte MG, Putti MC, Casini T, Dello Iacono N, Celli M, Vitucci A, Giuliano P, Peritore G, Renne S, Righi R, Positano V, De Sanctis V, Meloni A. The close link of pancreatic iron with glucose metabolism and with cardiac complications in thalassemia major: a large, multicenter observational study. Diabetes Care. 2020;43:2830–9.
Torlasco C, Cassinerio E, Roghi A, Faini A, Capecchi M, Abdel-Gadir A, Giannattasio C, Parati G, Moon JC, Cappellini MD, Pedrotti P. Role of T1 mapping as a complementary tool to T2* for non-invasive cardiac iron overload assessment. PLoS One. 2018;13:e0192890.
Meloni A, Martini N, Positano V, De Luca A, Pistoia L, Sbragi S, Spasiano A, Casini T, Bitti PP, Allò M, Sanna PMG, De Caterina R, Sinagra G, Pepe A. Myocardial iron overload by cardiovascular magnetic resonance native segmental T1 mapping: a sensitive approach that correlates with cardiac complications. J Cardiovasc Magn Reson. 2021;23:70. https://doi.org/10.1186/s12968-021-00765-w.
Casale M, Meloni A, Filosa A, Cuccia L, Caruso V, Palazzi G, Gamberini MR, Pitrolo L, Putti MC, D'Ascola DG, Casini T, Quarta A, Maggio A, Neri MG, Positano V, Salvatori C, Toia P, Valeri G, Midiri M, Pepe A. Multiparametric cardiac magnetic resonance survey in children with thalassemia major: a multicenter study. Circ Cardiovasc Imaging. 2015;8:e003230.
Meloni A, Pistoia L, Positano V, De Luca A, Martini N, Spasiano A, Fotzi I, Bitti PP, Visceglie D, Alberini G, Sinagra G, Pepe A, Cademartiri F. Increased myocardial extracellular volume is associated with myocardial iron overload and heart failure in thalassemia major. Eur Radiol. 2022;6:1266. https://doi.org/10.1007/s00330-022-09120-8.
Roghi A, Dellegrottaglie S, Pedrotti P, Pedretti S, Cassinerio E, Cappellini MD. Unexpected myocarditis in thalassaemia major patient screened for iron load cardiomyopathy. BMJ Case Reports. 2009;2009:bcr0820080811. https://doi.org/10.1136/bcr.08.2008.0811.
Marsella M, Borgna-Pignatti C, Meloni A, Caldarelli V, Dell'Amico MC, Spasiano A, Pitrolo L, Cracolici E, Valeri G, Positano V, Lombardi M, Pepe A. Cardiac iron and cardiac disease in males and females with transfusion-dependent thalassemia major: a T2* magnetic resonance imaging study. Haematologica. 2011;96:515–20.
Meloni A, Righi R, Missere M, Renne S, Schicchi N, Gamberini MR, Cuccia L, Lisi R, Spasiano A, Roberti MG, Zuccarelli A, Ait-Ali L, Festa P, Aquaro GD, Mangione M, Barra V, Positano V, Pepe A. Biventricular reference values by body surface area, age, and gender in a large cohort of well-treated thalassemia major patients without heart damage using a multiparametric CMR approach. J Magn Reson Imaging. 2021;53:61–70.
Macaione F, Meloni A, Positano V, Pistoia L, Barison A, Di Lisi D, Spasiano A, Campisi S, Spiga A, Righi R, Novo G, Novo S, Pepe A. The planimetric Grothoff's criteria by cardiac magnetic resonance can improve the specificity of left ventricular non-compaction diagnosis in thalassemia intermedia. Int J Cardiovasc Imaging. 2020;36:1105–12.
Ojha V, Ganga KP, Seth T, Roy A, Naik N, Jagia P, Gulati GS, Kumar S, Sharma S. Role of CMR feature-tracking derived left ventricular strain in predicting myocardial iron overload and assessing myocardial contractile dysfunction in patients with thalassemia major. Eur Radiol. 2021;31:6184–92. https://doi.org/10.1007/s00330-020-07599-7.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Electronic Supplementary Material
Short-axis cine stack of the follow-up scan (MP4 174 kb)
Short-axis cine stack (MP4 180 kb)
Four-chamber cine SSFP (MP4 187 kb)
Four-chamber SSFP cine view (MP4 172 kb)
Feature tracking strain analysis in a 4-chamber cine view (MP4 228 kb)
Short-axis cine stack (MP4 545 kb)
Short-axis cine stack (MP4 194 kb)
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Pepe, A., Sormani, P., Meloni, A., Torlasco, C. (2023). Iron Overload Cardiomyopathies. In: Barison, A., Dellegrottaglie, S., Pontone, G., Indolfi, C. (eds) Case-based Atlas of Cardiovascular Magnetic Resonance. Springer, Cham. https://doi.org/10.1007/978-3-031-32593-9_10
Download citation
DOI: https://doi.org/10.1007/978-3-031-32593-9_10
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-32592-2
Online ISBN: 978-3-031-32593-9
eBook Packages: MedicineMedicine (R0)